Wiadomości giełdowe

Najnowsze wiadomości finansowe · Zaktualizowano Maj 23, 2026

▬ mixed

Boom AI przyspiesza rozwój chińskiego przemysłu chipów, a popyt obciąża łańcuch dostaw

AI boom accelerates China's chip industry growth as demand strains supply chain

The panel discusses China's semiconductor capacity expansion, with a net takeaway that while China aims for 42% global capacity in …

Yahoo Finance · Mar 25, 2026
▬ mixed

CNBC anchor zszokowany spadkiem deficytu handlowego USA z 136 mld USD do 29 mld USD — najniższy poziom od 2009 roku. Czy Trump miał rację co do ceł?

CNBC anchor shocked by US trade deficit drop from $136B to $29B — the lowest since 2009. Was Trump right about tariffs?

The panel generally agreed that the $29.4B trade deficit was a one-off anomaly, with gold exports and imports accounting for …

Yahoo Finance · Mar 25, 2026
▬ mixed

ETF Bitcoin przyciągnęły 2,5 miliarda dolarów w ciągu miesiąca, zacierając prawie wszystkie dotychczasowe straty w tym roku

Bitcoin ETFs Draw in $2.5B in a Month, Close to Erasing YTD Losses

The panel's net takeaway is that while the $2.5B inflow into Bitcoin ETFs is notable, its sustainability is questionable due …

Yahoo Finance · Mar 25, 2026
LRCX
▬ mixed

Lam Research Corporation (LRCX) jest pozycjonowany, aby skorzystać na rosnącym złożeniu układów scalonych.

Lam Research Corporation (LRCX) is Positioned to Benefit from Growing Chip Complexity

The panelists have mixed views on LRCX, with concerns about China export risks and lack of specific financial data, but …

Yahoo Finance · Mar 25, 2026
▬ mixed

Ta Medicareńska Błąd w Wieku 65 Lat Może Prześladować Cię Resztę Życia

This Medicare Mistake at Age 65 Could Haunt You for the Rest of Your Life

The panel agrees that missing the 7-month Medicare enrollment window results in a permanent 10% penalty per year, which can …

Nasdaq · Mar 25, 2026
RKLB ROCK TSLA
▬ mixed

Lepszy akcyjny gigant przemysłowy: Tesla vs Rocket Lab

Better Industrial Stock: Tesla vs. Rocket Lab

The panel discusses Rocket Lab (RKLB) vs Tesla (TSLA), with RKLB's $816M Space Force contract and smaller market cap offering …

Nasdaq · Mar 25, 2026
▬ mixed

Obawy o recesję powracają: Oto dlaczego nie powinny one zmieniać Twojej strategii

Recession Fears Are Back: Here Is Why That Should Not Change Your Strategy

The panel agrees that dollar-cost averaging works historically, but there's no consensus on whether now is a good time to …

Nasdaq · Mar 25, 2026
NFLX
▬ mixed

Netflix Zrezygnował z Pozyskania Warner Bros. Discovery. Czy To Był Mądry Ruch?

Netflix Walked Away From Warner Bros. Was That a Smart Move?

Netflix's decision to walk away from the Warner Bros. Discovery deal at $83 billion was primarily a capital-allocation decision, preserving …

Nasdaq · Mar 25, 2026
AAPL
▼ bear…

Kontrakty terminowe sugerują umiarkowany wzrost na Wall Street

Futures Suggest Wall Street To Open Moderately Up

Panel consensus suggests a cautious, bearish outlook. Markets show resilience but underlying data points to labor market cooling, geopolitical risks, …

Nasdaq · Mar 25, 2026
▬ mixed

Powrót Hugo Barra do Meta 5 lat po odejściu podkreśla pilność Zuckerberga w dziedzinie AI

Hugo Barra's return to Meta 5 years after exit underscores Zuckerberg's AI urgency

Meta's pivot to AI agents is a significant shift, but the panel is divided on its potential success. While some …

CNBC · Mar 25, 2026
▬ mixed

Startup ds Legal AI Harvey wyceniony na 11 miliardów dolarów w rundzie finansowania, ponieważ VC rozpraszają zakłady poza modelowymi firmami

Legal AI startup Harvey valued at $11 billion in funding round, as VCs spread bets beyond model companies

The panel is divided on Harvey's $11B valuation, with concerns about sustainability, competition, and liability risks, but also acknowledging its …

CNBC · Mar 25, 2026
▬ mixed

Merck kupi Terns Pharmaceuticals za 6,7 miliarda dolarów, aby wzmocnić swoją linię produktów przeciwnowotworowych

Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline

Merck's $6.7B acquisition of Terns' leukemia drug is a high-stakes gamble to bridge the Keytruda patent cliff in 2028. While …

CNBC · Mar 25, 2026